Atea Pharmaceuticals Inc (AVIR) — Financial Flexibility Index
Atea Pharmaceuticals Inc (AVIR) has a Financial Flexibility Index of -1.39x as of March 2026. Free cash flow of $-46.39 Million (operating CF $-46.39 Million minus capex $0.00) represents -1% of total liabilities ($33.37 Million). Check how strategically is Atea Pharmaceuticals Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Atea Pharmaceuticals Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Atea Pharmaceuticals Inc across 8 annual periods. See AVIR working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Atea Pharmaceuticals Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Atea Pharmaceuticals Inc. For the full company profile including market capitalisation, see market value of Atea Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.32x | $-132.03 Million | $-132.03 Million | $39.78 Million | ▲ +36.8% |
| 2024 | -5.25x | $-135.50 Million | $-135.50 Million | $25.80 Million | ▼ -144.6% |
| 2023 | -2.15x | $-85.39 Million | $-85.39 Million | $39.78 Million | ▲ +52.9% |
| 2022 | -4.55x | $-119.04 Million | $-120.98 Million | $26.14 Million | ▼ -228.8% |
| 2021 | -1.39x | $-87.00 Million | $-87.00 Million | $62.81 Million | ▼ -247.4% |
| 2020 | 0.94x | $296.76 Million | $296.73 Million | $315.83 Million | ▲ +625.4% |
| 2019 | -0.18x | $-12.81 Million | $-12.81 Million | $71.64 Million | ▼ -60.9% |
| 2018 | -0.11x | $-7.90 Million | $-7.91 Million | $71.02 Million | — |